# Tactile Systems Technology, Inc. (TCMD) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/TCMD
## Company Profile
- Ticker: TCMD
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 22.01 USD
- Market cap: 550598306.6 USD
- Last updated: 2026-09-03
## Business Overview
### At-Home Chronic-Care Therapies
Tactile Medical develops and markets at-home therapies for underserved chronic conditions. Its products help patients manage long-term diseases outside hospitals and clinics while supporting clinician-directed treatment plans.
### Lymphedema Portfolio
The company's Flexitouch systems deliver pneumatic compression therapy for lymphedema and related swelling disorders. Its acquisition of LymphaTech broadens the portfolio across the lymphedema-care continuum with measurement and monitoring capabilities.
### Airway Clearance
AffloVest is a wearable high-frequency chest-wall oscillation system used by patients with chronic respiratory conditions who need airway-clearance therapy. A next-generation system expands Tactile Medical beyond its core lymphedema franchise.
### Compression and Distribution
Tactile Medical also distributes complementary products such as the MyoSleeve wearable compression device. Its commercial model combines direct patient support, clinician engagement, reimbursement services and relationships with government and private payers.
## Why The Stock Is Moving

As of Sep 3, 2026, TCMD closed down 1.78% at $22.01. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-10 20:05 EST — [Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/TCMD/tactile-systems-technology-inc-reports-second-quarter-2026-financial-results-24c49bb2) — Source: Tactile Systems Technology, Inc.
- 2026-07-21 20:05 EST — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004) — Source: Tactile Systems Technology, Inc.
- 2026-07-13 12:00 EST — [Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients](https://biopharmsignal.com/news/TCMD/tactile-medical-enters-exclusive-u-s-distribution-agreement-with-elastimed-for-i-116aea64) — Source: Tactile Systems Technology, Inc.
- 2026-06-02 12:00 EST — [Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy](https://biopharmsignal.com/news/TCMD/tactile-medical-launches-next-generation-afflovestr-airway-clearance-therapy) — Source: Tactile Systems Technology, Inc.
- 2026-05-20 20:05 EST — [Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference](https://biopharmsignal.com/news/TCMD/tactile-medical-to-present-at-the-william-blair-46th-annual-growth-stock-conference) — Source: Tactile Systems Technology, Inc.